Prescription patterns of venetoclax in acute myeloid leukemia-Reference-Cited by-同舟云学术

Prescription patterns of venetoclax in acute myeloid leukemia

Published:2024-07 Issue:4 Volume:42 Page:
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Ucciero Andrealuna¹^ORCID,Traversa Giuseppe²,Pisterna Alessia¹,Cardinali Valeria³,Sciabolacci Sofia³,Poloni Antonella⁴,Capelli Debora⁴,Gaidano Gianluca⁵,Patriarca Andrea⁵,Lunghi Monia⁵

Affiliation:

1. University Hospital Maggiore della Carità—Hospital Pharmacy Novara Italy

2. MD/Epidemiologist Rome Italy

3. University of Perugia and AOU Santa Maria della Misericordia—Institute of Hematology and Oncology‐Hematology Research Center Perugia Italy

4. Hematology Clinic, Department of Clinical and Molecular Sciences Polytechnic University of Marche and United Hospitals of Ancona Ancona Italy

5. Division of Hematology, Department of Translational Medicine University of Eastern Piedmont and AOU Maggiore della Carità Novara Italy

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3298

Reference10 articles.

1. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

2. Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia

3. Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience

4. Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients

5. AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia